A clinical study of total glucosides of paeony for treatment of patients with systemic lupus erythematosus accompanied by leucopenia
- VernacularTitle:白芍总苷治疗并发血白细胞减少系统性红斑狼疮患者的临床研究
- Author:
Hong MO
;
Yadi CHEN
- Publication Type:Journal Article
- Keywords:
Systemic lupus erythematosus;
Total glucosides of paeony;
Low white blood cell
- From:
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
2014;26(2):104-107
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the therapeutic efficacy and safety of using total glucosides of paeony (TGP)for treatment of patients with systemic lupus erythematosus(SLE)accompanied by low white blood cell(WBC) count. Methods According to the revised SLE Classification Standard of American College of Rheumatology in 1982,62 cases of SLE accompanied by low WBC consistent with the standard were randomly divided into experimental group(31 cases)and control group(31 cases). The conventional therapy plus prednisone of 0.5-1.0 mg?kg-1?d-1 was applied for treatment in both groups,and in the experimental group,additionally TGP(0.6 g orally each time,three times a day)was given. The therapeutic course in both groups was 12 weeks. The changes in following parameters of two groups were noted at baseline and after treatment:WBC,complement C3,erythrocyte sedimentation rate (ESR),C-reactive protein(CRP),liver and kidney function,etc;the SLE disease activity index(SLEDAI)score, the therapeutic effects and incidence of adverse reactions were evaluated in two groups. Results After 12 weeks of treatment,WBC and C3 were significantly increased,and ESR,CRP,SLEDAI were significantly decreased in the two groups,the improvement being more significant in the experimental group〔WBC(×109/L):5.38±1.32 vs. 4.16±1.39,complement C3(g/L):1.28±0.32 vs. 0.86±0.26,ESR(mm/1 h):22.36±5.26 vs. 28.85±8.56, CRP(g/L):23.25±8.26 vs. 28.32±8.52,SLEDAI(score):2.58±1.86 vs. 4.18±2.31,P<0.05 or P<0.01〕. Compared with the control group,the total effective rate was significantly higher in experimental group〔93.55%(29/31) vs. 70.97%(22/31)〕,the average daily dosage of prednisone and its total dosage in 12 weeks were significantly less in experimental group〔prednisone dosage(mg/d):16.26±9.85 vs. 25.32±9.68,the total dosage of prednisone (mg)2 016.5±125.6 vs. 2 983.6±152.8,both P<0.01〕. The incidence of infection in experimental group was obviously lower than that in the control group(9.68% vs. 35.48%,P<0.05),there was no significantly statistical difference in incidence of adverse reactions between experimental group and control group(12.90%vs. 16.13%,P>0.05). Conclusion TGP is a safe and effective treatment for patients with SLE accompanied by low WBC,and it also can significantly reduce the use of glucocorticoid dosage and the incidence of infection in such patients.
